|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 600 13th Street, NW |
Address2 | Suite 500 |
City | Washington |
State | DC |
Zip Code | 20005 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 26683-12
|
||||||||
|
6. House ID# 305940000
|
TYPE OF REPORT | 8. Year | 2023 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Leah Evangelista |
Date | 1/22/2024 7:03:55 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Issues regarding childrens health care coverage and access to care under Medicaid, CHIP, the Exchanges, and private insurance
Issues regarding the annual Notice of Benefit and Payment Parameters for the Exchanges and private insurance
Issues regarding the implementation of the ACE Kids Act
H.R. 2412 The Helping Kids Cope Act
S.2372/HR. 4758 - Accelerating Kids Access to Care Act
Issues regarding childrens and mothers health specifically continuous eligibility for children in Medicaid and CHIP, CHIP permanency
Issues regarding childrens mental health and the national emergency in childrens mental health, including mental health parity, the mental health workforce and related access issues.
Issue regarding Medicaid supplemental payments and directed payments
Issues related to Health Information Technology, interoperability and information blocking
Pediatric Access to Critical Healthcare (PATCH) Act, and issues regarding pediatric health care infrastructure and capacity
Issues regarding the importance of Medicaid to children, including military and veteran families
Issues regarding Medicaid support for providers caring for children on Medicaid, including DSH payments
FY 2023 and FY 2024 Senate and House Labor-HHS appropriations provisions - Children's Hospitals Graduate Medical Education (CHGME) program funding
Issues regarding Children's Hospitals Graduate Medical Education (CHGME) program reauthorization
Issues related to 340B Drug Pricing Program, prescription drug pricing, drug shortages, high-cost drugs/therapies and pharmaceutical supply chain, including H.R. 3290
Issues related to pediatric workforce and the Pediatric Specialty Loan Repayment Program
S. 3029/H.R. 6085 PREEMIE Reauthorization Act
Issues regarding the Medicaid unwinding and impact of the pandemic, increased FMAP funding, and the impact of COVID-19 on childrens hospitals and children, the pediatric supply chain, and pediatric residency programs
Issues regarding COVID-19 vaccination efforts for children
Issues regarding surprise billing, bad debt, and price transparency in health care
Issues regarding the Public Health Emergency and response on RSV/flu
Issues regarding the reauthorization of the Pandemic and All-Hazards Preparedness Act and emergency preparedness
Issues related to Emergency Medical Services for Children reauthorization
Issues regarding food security and nutrition
Issues regarding drugs and medical device shortages and high costs
VALID Act/laboratory developed tests
Issues regarding the uptake of childhood vaccines
Issues regarding prescribing drugs via telehealth
H.R. 1117, Advancing Safe Medications for Moms and Babies Act of 2023
Issues regarding the Public Health Emergency Unwinding
Issues involving Site Neutral payment legislation, including H.R. 3281 and H.R. 3561
S. 1884/H.R. 3713, Mental Health Services for Students Act
The Pursuing Equity in Mental Health America Act
H.R. 2389, The Resident Shortage Reduction Act
S. 1774/H.R. 3761 the Assist Act
H.R. 3633, the Prevent HPV Cancers Act
H.R. 2665, Supporting Safety Net Hospitals Act
H.R. 2584/S.2768, Safety form Violence for Healthcare employees (Save) Act
S. 923, Better Mental Health Care for Americans Act
H.R. 3046, Medical Student Education Authorization Act
S. 2556, Improving CARE for Youth Act
S. 2647/H.R. 5012, SHINE for Autumn Act of 2023
S. 923/H.R. 4933, Mental Health Professionals Workforce Shortage Loan Repayment Act of 2023
S.2476/H.R. 4884, Mental Health for Latinos Act of 2023
S. 2362/H.R. 3008, Drug Shortage Prevention Act of 2023
H.R. 3759, Barriers to Suicide Act of 2023
S. 1409, Kids Online Safety Act
S. 1769/H.R. 3805, the Kickstarting Innovative Demonstrations Supporting (KIDS) Health Act.
H.R. 5804, Mental Health Infrastructure Improvement Act
H.R. 5976 /S. 3060 Youth Mental Health Research Act
S. 3364, Kid PROOF Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Executive Office of the President (EOP), Labor - Dept of (DOL), Treasury - Dept of, Food & Drug Administration (FDA), Agriculture - Dept of (USDA), Natl Oceanic & Atmospheric Administration (NOAA), Centers For Disease Control & Prevention (CDC), Drug Enforcement Administration (DEA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Elizabeth |
Brown |
|
|
|
Natalie |
Torentinos |
|
|
|
Darian |
Burrell-Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Issues regarding childrens health care coverage and access to care under Medicaid and CHIP.
Issues related to eligibility and enrollment, access to care and payment in response to CMS RFI on Medicaid and CHIP
Issues related to implementation of aspects of childrens health coverage under Medicaid and CHIP, including unwinding of the Public Health Emergency.
Issues regarding childrens and mothers health specifically continuous eligibility for children in Medicaid and CHIP, CHIP permanency,
Issues regarding mental health parity, the mental health workforce and the facilitating integrated within Medicaid and CHIP
Issue regarding Medicaid supplemental payments, including DSH and directed payments
Issues regarding the implementation of the ACE Kids Act
S.2372/HR. 4758 - Accelerating Kids Access to Care Act
Issues regarding the importance of Medicaid to military and veteran families
Issues regarding the passage and implementation of COVID-19 relief packages, increased FMAP funding, and the impact of COVID-19 on childrens hospitals, the pediatric supply chain, and pediatric residency programs.
Issues related to pediatric telehealth
Issues regarding prescribing drugs via telehealth
H.R. 1117, Advancing Safe Medications for Moms and Babies Act of 2023
Issues regarding the Public Health Emergency Unwinding
Issues regarding 340B including, H.R. 3561
Issues regarding payment for organ procurement
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Elizabeth |
Brown |
|
|
|
Natalie |
Torentinos |
|
|
|
Darian |
Burrell-Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
Issues regarding efforts to improve health care delivery for children covered by TRICARE
Issues regarding the importance of Medicaid to military and veteran families
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Elizabeth |
Brown |
|
|
|
Jan |
Kaplan |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Funding for Health Resources and Services Administration (HRSA), including Childrens Hospitals Graduate Medical Education program, the Maternal and Child Health Block Grant, and Family 2 Family Centers
Funding for the Centers for Disease Control and Prevention gun violence prevention research
Funding for the Substance Abuse and Mental Health Services Administration (SAMHSA) Community
Mental Health Services Block Grant, including a set aside for prevention and early intervention services
Funding for the Pediatric Mental Health Care Access Program
Funding for and implementation of Pediatric Subspecialty Loan Forgiveness Program
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
|
Elizabeth |
Brown |
|
|
|
Leah |
Evangelista |
|
|
|
Aimee |
Ossman |
|
|
|
Jan |
Kaplan |
|
|
|
Darian |
Burrell-Clay |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 3046, Medical Student Education Authorization Act of 2023
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Cynthia |
Whitney |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |